National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$24.95
add to cart

Rights & Permissions

topleft topright

Oral Contraceptives and Breast Cancer (1991)
Institute of Medicine (IOM)

Citation Manager

. "Appendix B: Oral Contraceptives and Breast Cancer: Review of the Epidemiological Literature." Oral Contraceptives and Breast Cancer. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
118
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Oral Contraceptives & Breast Cancer

McPherson and colleagues (1986) have suggested that the reason for the discrepant findings is that the studies that showed no association were unable to assess risk after a long potential latent period. As shown in Table B-18, however, four studies have shown that risk is not particularly enhanced more than a decade after exposure to oral contraceptives before a first birth (McPherson et al., 1987; Vessey et al., 1989; Paul et al., 1990) or after 15 years following the first birth in women who used the pill prior to that birth (Schlesselman et al., 1988).

It should also be noted that in two of the studies in Table B-16

TABLE B-15 Relative Risk of Breast Cancer in Women Who Used Oral Contraceptives Before and After Diagnosis of a Benign Breast Lesion

   

Estimate of Relative Risk (Confidence Interval)a

First Author (Date)

Use of Oral Contraceptives

Before Benign Breast Disease

After Benign Breast Disease

CASH b (1986)

Any

0.7(0.5,0.97)

0.8(0.5,1.2)

Stanford (1989)

Any

1.22(0.7,2.1)

0.87(0.6,1.3)

 

<5 years

1.48(0.8,2.7)

0.91(0.5,1.5)

 

>5 years

0.55(0.2,1.7)

0.80(0.4,1.5)

WHO b (1990)

Any

1.30(0.75,2.27)

0.97(0.54,1.72)

Summary relative risk

Any

0.90[0.70,1.16] c

0.86[0.66,1.12] d

a Confidence interval of 95 percent used; [ ] = confidence intervals estimated by approximate methods.

b CASH = Cancer and Steroid Hormone Study; WHO = World Health Organization.

c p value of chi-square test for heterogeneity = .08.

d p value of chi-square test for heterogeneity = .87.

Page
118